![](/img/cover-not-exists.png)
A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer
Bantie, Laychiluh, Tadesse, Solomon, Likisa, Jimma, Yu, Mingfeng, Noll, Benjamin, Heinemann, Gary, Lokman, Noor A., Ricciardelli, Carmela, Oehler, Martin K., Beck, Andrew, Pradhan, Rupal, Milne, RoberJournal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2020.09.012
Date:
September, 2020
File:
PDF, 5.07 MB
2020